Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oral mucosal dendritic cell antigen-uptake receptors represent a functional class of pattern recognition receptors, primarily C-type lectins, expressed on the surface of dendritic cells (DCs) and Langerhans cells (LCs) in the oral epithelium and lamina propria [1]. Key members include Langerin (CD207), DC-SIGN (CD209), and the Mannose Receptor (CD206), which are specialized for the capture and internalisation of glycosylated antigens [2]. These receptors facilitate the transport of antigens to local lymph nodes, where they are presented to T cells to initiate either an active immune response or, more commonly in the oral environment, immune tolerance [3]. This tolerogenic property is exploited in sublingual immunotherapy (SLIT), where allergens are delivered to these receptors to treat allergic rhinitis and asthma [4]. Furthermore, these receptors are being investigated as targets for needle-free mucosal vaccines designed to protect against pathogens like HIV or influenza [5]. The density and distribution of these receptors across different regions of the oral cavity, such as the sublingual versus buccal mucosa, significantly influence the efficacy of transmucosal therapeutic interventions [1][2]. [1] Hovav, A. H. (2014). Dendritic cells of the oral mucosa. Mucosal Immunology. [2] Allam, J. P., et al. (2008). Characterization of dendritic cells from human oral mucosa. Journal of Allergy and Clinical Immunology. [3] Mascarell, L., et al. (2008). The sublingual mucosa as a site for vaccination. Vaccine. [4] Canonica, G. W., et al. (2014). Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organization Journal. [5] Moingeon, P. (2013). Sublingual immunotherapy: from the mucosa to the lymph nodes. Clinical & Experimental Allergy.
These receptors facilitate the capture and internalisation of antigens by dendritic cells in the oral mucosa, followed by processing and presentation on MHC molecules to modulate T-cell responses, often promoting systemic immune tolerance or mucosal immunity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oral mucosal dendritic cell antigen-uptake receptors.